• Featured Product
  • KD/KO Validated

UCH-L1/PGP9.5 Monoklonaler Antikörper

UCH-L1/PGP9.5 Monoklonal Antikörper für WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

Hausschwein, human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), ELISA

Konjugation

Unkonjugiert

CloneNo.

1C9E11

Kat-Nr. : 66230-1-PBS

Synonyme

PGP9.5, UCHL1, UCHL1/PGP9.5, 1C9E11, EC:3.4.19.12



Geprüfte Anwendungen

Produktinformation

66230-1-PBS bindet in WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), ELISA UCH-L1/PGP9.5 und zeigt Reaktivität mit Hausschwein, human, Maus, Ratten

Getestete Reaktivität Hausschwein, human, Maus, Ratte
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen UCH-L1/PGP9.5 fusion protein Ag6547
Vollständiger Name ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
Berechnetes Molekulargewicht 25 kDa
Beobachtetes Molekulargewicht 27 kDa
GenBank-ZugangsnummerBC000332
Gene symbol UCHL1
Gene ID (NCBI) 7345
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Ubiquitin C-terminal hydrolase L1 (UCHL1) was originally identified as a neuronal protein that accounts for nearly 2% of total brain proteins. UCHL1 activity protects neurons from hypoxic injury, and binding of stroke-induced reactive lipid species to the cysteine 152 (C152) of UCHL1 unfolds the protein and disrupts its function. Reduced hydrolytic activity of mutant UCHL1 is implicated in the pathophysiologic process of Parkinson's and Alzheimer's disease due to abnormal neurotoxic protein aggregation. (PMID: 31356902, PMID: 30760601)